Credit Suisse’s 4D Pharma PLC LBPS Stock Holding History

Credit Suisse’s Portfolio LBPS Stock Details LBPS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,638	Closed	-$3K	–	4549
2022 Q2	$3K	Buy	+1,638	New	+$5.57K	﹤0.01%	3784

Credit Suisse's LBPS Position: Q3 2022 in Review

Credit Suisse sold out of 4D Pharma PLC (LBPS) in Q3 2022, closing a stake of 1,638 shares — an estimated $3K sold.

Credit Suisse first reported a position in LBPS in Q2 2022 and held it in 1 quarter. The position peaked at $3K in Q2 2022. 1 fund tracked by Wall St. Rank holds LBPS as of Q3 2022.

Credit Suisse reported no remaining 4D Pharma PLC position as of Q3 2022 after selling out during the quarter.
Credit Suisse sold 1,638 4D Pharma PLC shares in Q3 2022, an estimated $3K.
Credit Suisse first reported a position in 4D Pharma PLC in Q2 2022 and held it in 1 quarter.
Credit Suisse's 4D Pharma PLC position peaked at $3K in Q2 2022.
1 fund tracked by Wall St. Rank held 4D Pharma PLC as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.